title: [Indications and early results of splenectomy in hematologic diseases].
abstract: In this retrospective study, we present 245 patients with various hematological diseases, who had undergone splenectomy for diagnostic or therapeutic purpose in our Department during the last 20-year period (1971-1991). There were 138 men (56%) and 107 women (44%), with a mean age of 49 years. The hematological diseases, for which the splenectomy had been performed, were according to the frequency of admittance: hemolytic anemia, complicated or not by gallstone formation, Werlhoff disease (thrombocytopenic purpura), Hodgkin's disease, hairy-cell leukemia, chronic lymphatic leukemia, non-Hodgkin lymphoma. A drain was placed in the splenic bed in all patients. All patients received anticoagulant therapy and antibiotics as well. Pneumococcal vaccination had been done systematically during the preoperative period. All patients received prophylaxis with a Penicillin for two years postoperatively. During the immediate postoperative period the mortality (1.2% OPSI: 1 case) and the morbidity (3.5% OPSI: 1 case) rates were very low. In conclusion, splenectomy in patients with hematological diseases is a safe procedure, even in high risk patients, but it requires a preoperative preparation and a close cooperation between surgeon and hematologist during the peri- and postoperative periods. Additionally, we have to notice that the possibility of an acute serious infection exists for any patient during the rest of his life.
authors.affiliation: Clinique propédeutique chirurgicale de l'Université d'Athènes, Grèce.
authors.forename: C
authors.initials: C
authors.lastname: Fotiadis
authors.forename: C
authors.initials: C
authors.lastname: Kontzoglou
authors.forename: P
authors.initials: P
authors.lastname: Dousaitou
authors.forename: M
authors.initials: M
authors.lastname: Sehas
authors.forename: G R
authors.initials: GR
authors.lastname: Skalkeas
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006402:Hematologic Diseases / Q000601:surgery*; D006801:Humans; D017053:Infection Control; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011292:Premedication; D012189:Retrospective Studies; D012307:Risk Factors; D013156:Splenectomy
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: Indications et résultats précoces des splénectomies pour affections hématologiques.